2nd International Conference on Fostering Interdisciplinary Research In Health Sciences (ICFIRHS) 2019 (01-May-2019)        |

Journal :   Research Journal of Pharmacy and Technology

Volume No. :   8

Issue No. :  4

Year :  2015

Pages :   369-375

ISSN Print :  0974-3618

ISSN Online :  0974-360X


Registration

Allready Registrered
Click to Login

Studies on the anti-fertility efficacy of Abrime and Embrelin, the compounds of plant origin on mouse testis and uterus



Address:   Kavya R1, Vivekanandan O.S2., and R. Radhai3
1Department of Pharmacology, Saveetha Dental College, Poonthamalle, Chennai - 600077. India.
2Department of Biotechnology / Bioinformatics, Vels University, Pallavaram, Chennai - 600117, India.
3Research Student, Department of Biotechnology, Vels University, Chennai – 600117, India.
*Corresponding Author
DOI No: 10.5958/0974-360X.2015.00062.1

ABSTRACT:
The abortifacient contraceptive drugs (Allopathic) available in the market are regularly taken by women. It may result with many side effects and damage the vital organs, genetic material leading to mutational changes which in-turn prove to be carcinogenic. Abrine and Embelin, the antifertility agents of plant orgin were tested on the uterus, testis, foetuses of mice. The results were indicated that these compounds are toxic to the foetuses, uterus and testis of mice by reducing the spermatozoid production, hypertrophic and haemorrhageic uterus and also anomalies in the morphology and skeletal system of foetuses. The present study revealed that these compounds are also inducing high mutation rate. Hence, these compounds may be used as antifertility or abortifacient agents after further analysis for the safe usage by women as well as men.
KEYWORDS:
Abortifacient, Mutation rate, Hypertrophic, Skeletal system, Antifertility agents.
Cite:
Kavya R, Vivekanandan O.S, R. Radhai. Studies on the anti-fertility efficacy of Abrime and Embrelin, the compounds of plant origin on mouse testis and uterus. Research J. Pharm. and Tech. 8(4): April, 2015; Page 369-375.
[View HTML]      [View PDF]



Visitor's No. :   641895